Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
226 | 3873 | 37.8 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
99 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 74452 |
107 | 2 | HEPATITIS B VIRUS//HEPATITIS B//CHRONIC HEPATITIS B | 25371 |
226 | 1 | CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE | 3873 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHRONIC HEPATITIS B | authKW | 2756055 | 21% | 44% | 795 |
2 | ENTECAVIR | authKW | 2011429 | 9% | 71% | 359 |
3 | LAMIVUDINE | authKW | 1884226 | 15% | 41% | 586 |
4 | ADEFOVIR | authKW | 903869 | 5% | 63% | 183 |
5 | TELBIVUDINE | authKW | 648758 | 3% | 75% | 110 |
6 | ADEFOVIR DIPIVOXIL | authKW | 604123 | 3% | 63% | 121 |
7 | HEPATITIS B VIRUS | authKW | 587427 | 17% | 11% | 652 |
8 | NUCLEOSTIDE ANALOGUES | authKW | 486202 | 2% | 75% | 82 |
9 | LAMIVUDINE RESISTANCE | authKW | 345542 | 1% | 80% | 55 |
10 | HBV DNA | authKW | 329212 | 4% | 30% | 140 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 133707 | 56% | 1% | 2162 |
2 | Virology | 24853 | 20% | 0% | 756 |
3 | Infectious Diseases | 7765 | 14% | 0% | 538 |
4 | Pharmacology & Pharmacy | 1880 | 15% | 0% | 584 |
5 | Microbiology | 519 | 6% | 0% | 243 |
6 | Medicine, General & Internal | 498 | 7% | 0% | 268 |
7 | Medicine, Research & Experimental | 48 | 3% | 0% | 100 |
8 | Medical Laboratory Technology | 37 | 1% | 0% | 30 |
9 | Health Care Sciences & Services | 16 | 1% | 0% | 34 |
10 | Pediatrics | 14 | 2% | 0% | 68 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEPATOL | 90869 | 7% | 4% | 263 |
2 | NKC GASTROENTEROL HEPATOL | 90066 | 1% | 57% | 20 |
3 | LIVER UNIT | 83180 | 6% | 5% | 221 |
4 | U871 | 76595 | 1% | 29% | 33 |
5 | U271 | 65851 | 1% | 23% | 36 |
6 | SERV HEPATOL | 61792 | 2% | 8% | 94 |
7 | HEPATOL UNIT | 54196 | 2% | 10% | 68 |
8 | HEPATITIS | 49714 | 2% | 10% | 66 |
9 | TORONTO WESTERN GEN HOSP | 44389 | 0% | 43% | 13 |
10 | MED HEPATOL | 43619 | 1% | 23% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF VIRAL HEPATITIS | 116780 | 5% | 8% | 181 |
2 | ANTIVIRAL THERAPY | 93306 | 4% | 8% | 149 |
3 | HEPATOLOGY INTERNATIONAL | 73869 | 2% | 12% | 78 |
4 | JOURNAL OF HEPATOLOGY | 47907 | 6% | 3% | 215 |
5 | LIVER INTERNATIONAL | 43139 | 3% | 5% | 118 |
6 | HEPATOLOGY | 37777 | 6% | 2% | 239 |
7 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 23944 | 4% | 2% | 142 |
8 | HEPATITIS MONTHLY | 15689 | 1% | 5% | 40 |
9 | JOURNAL OF MEDICAL VIROLOGY | 14757 | 3% | 2% | 120 |
10 | HEPATOLOGY RESEARCH | 11652 | 2% | 2% | 63 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRONIC HEPATITIS B | 2756055 | 21% | 44% | 795 | Search CHRONIC+HEPATITIS+B | Search CHRONIC+HEPATITIS+B |
2 | ENTECAVIR | 2011429 | 9% | 71% | 359 | Search ENTECAVIR | Search ENTECAVIR |
3 | LAMIVUDINE | 1884226 | 15% | 41% | 586 | Search LAMIVUDINE | Search LAMIVUDINE |
4 | ADEFOVIR | 903869 | 5% | 63% | 183 | Search ADEFOVIR | Search ADEFOVIR |
5 | TELBIVUDINE | 648758 | 3% | 75% | 110 | Search TELBIVUDINE | Search TELBIVUDINE |
6 | ADEFOVIR DIPIVOXIL | 604123 | 3% | 63% | 121 | Search ADEFOVIR+DIPIVOXIL | Search ADEFOVIR+DIPIVOXIL |
7 | HEPATITIS B VIRUS | 587427 | 17% | 11% | 652 | Search HEPATITIS+B+VIRUS | Search HEPATITIS+B+VIRUS |
8 | NUCLEOSTIDE ANALOGUES | 486202 | 2% | 75% | 82 | Search NUCLEOSTIDE+ANALOGUES | Search NUCLEOSTIDE+ANALOGUES |
9 | LAMIVUDINE RESISTANCE | 345542 | 1% | 80% | 55 | Search LAMIVUDINE+RESISTANCE | Search LAMIVUDINE+RESISTANCE |
10 | HBV DNA | 329212 | 4% | 30% | 140 | Search HBV+DNA | Search HBV+DNA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SARIN, SK , KUMAR, M , LAU, GK , ABBAS, Z , CHAN, HLY , CHEN, CJ , CHEN, DS , CHEN, HL , CHEN, PJ , CHIEN, RN , ET AL (2016) ASIAN-PACIFIC CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF HEPATITIS B: A 2015 UPDATE.HEPATOLOGY INTERNATIONAL. VOL. 10. ISSUE 1. P. 1 -98 | 226 | 38% | 48 |
2 | TERRAULT, NA , BZOWEJ, NH , CHANG, KM , HWANG, JP , JONAS, MM , MURAD, MH , (2016) AASLD GUIDELINES FOR TREATMENT OF CHRONIC HEPATITIS B.HEPATOLOGY. VOL. 63. ISSUE 1. P. 261 -283 | 84 | 73% | 95 |
3 | LIAW, YF , KAO, JH , PIRATVISUTH, T , CHAN, HLY , CHIEN, RN , LIU, CJ , GANE, E , LOCARNINI, S , LIM, SG , HAN, KH , ET AL (2012) ASIAN-PACIFIC CONSENSUS STATEMENT ON THE MANAGEMENT OF CHRONIC HEPATITIS B: A 2012 UPDATE.HEPATOLOGY INTERNATIONAL. VOL. 6. ISSUE 3. P. 531 -561 | 138 | 75% | 326 |
4 | LOK, ASF , MCMAHON, BJ , (2007) CHRONIC HEPATITIS B.HEPATOLOGY. VOL. 45. ISSUE 2. P. 507 -539 | 138 | 59% | 1421 |
5 | PAPATHEODORIDIS, G , BUTI, M , CORNBERG, M , JANSSEN, H , MUTIMER, D , POL, S , RAIMONDO, G , (2012) EASL CLINICAL PRACTICE GUIDELINES: MANAGEMENT OF CHRONIC HEPATITIS B VIRUS INFECTION.JOURNAL OF HEPATOLOGY. VOL. 57. ISSUE 1. P. 167 -185 | 113 | 58% | 788 |
6 | ASAHINA, Y , HAYASHI, N , HIRAMATSU, N , IZUMI, N , KOIKE, K , KUMADA, H , KUROSAKI, M , OKETANI, M , SUZUKI, F , TAKIKAWA, H , ET AL (2014) JSH GUIDELINES FOR THE MANAGEMENT OF HEPATITIS B VIRUS INFECTION.HEPATOLOGY RESEARCH. VOL. 44. ISSUE . P. 1 -58 | 215 | 67% | 3 |
7 | DIENSTAG, JL , (2008) DRUG THERAPY - HEPATITIS B VIRUS INFECTION.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 359. ISSUE 14. P. 1486-1500 | 82 | 84% | 459 |
8 | ALMASRI, J , LOK, ASF , MCMAHON, BJ , BROWN, RS , WONG, JB , AHMED, AT , FARAH, W , ALAHDAB, F , BENKHADRA, K , MOUCHLI, MA , ET AL (2016) ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B VIRAL INFECTION IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.HEPATOLOGY. VOL. 63. ISSUE 1. P. 284 -306 | 62 | 89% | 15 |
9 | FUNG, J , LAI, CL , SETO, WK , YUEN, MF , (2011) NUCLEOSIDE/NUCLEOTIDE ANALOGUES IN THE TREATMENT OF CHRONIC HEPATITIS B.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 66. ISSUE 12. P. 2715 -2725 | 106 | 85% | 55 |
10 | ZOULIM, F , LOCARNINI, S , (2009) HEPATITIS B VIRUS RESISTANCE TO NUCLEOS(T)IDE ANALOGUES.GASTROENTEROLOGY. VOL. 137. ISSUE 5. P. 1593 -1608 | 87 | 78% | 270 |
Classes with closest relation at Level 1 |